Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

Mark Y CHAN; Mauricio G COHEN; David A VORCHHEIMER; Nicholas CHRONOS; Chiara MELLONI; John H ALEXANDER; Robert A HARRINGTON; Ross M TONKENS; Richard C BECKER; Christopher P RUSCONI; Christopher K DYKE; Shelley K MYLES; Laura G ABERLE; MIN MIN LIN; James WALDER; Steven R STEINHUBL; Ian C GILCHRIST; Neal S KLEIMAN

doi:10.1161/CIRCULATIONAHA.107.745687

Back

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

Journal article

Open access

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

Mark Y CHAN, Mauricio G COHEN, David A VORCHHEIMER, Nicholas CHRONOS, Chiara MELLONI, John H ALEXANDER, Robert A HARRINGTON, Ross M TONKENS, Richard C BECKER, Christopher P RUSCONI, …

Circulation (New York, N.Y.), Vol.117(22), pp.2865-2874

2008

DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.745687

PMID: 18506005

Abstract

Cardiology. Vascular system

Heart

Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous

Biological and medical sciences

Medical sciences

Coronary heart disease

Blood and lymphatic vessels

Files and links (1)

url

https://doi.org/10.1161/CIRCULATIONAHA.107.745687View

Published (Version of record) Open

Metrics

15 Record Views

116 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 2 Chemistry; 2.145 Biosensors; 2.145.243 Aptamer
Web Of Science research areas: Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
Creators: Mark Y CHAN - Duke Clinical Research Institute, Durham, NC, United States
Mauricio G COHEN - Division of Cardiology University of North Carolina, Chapel Hill, United States
David A VORCHHEIMER - Mount Sinai Medical Center New York University Hospital, New York, United States
Nicholas CHRONOS - Saint Joseph's Translational Research Institute, Atlanta, Ga, United States
Chiara MELLONI - Duke Clinical Research Institute, Durham, NC, United States
John H ALEXANDER - Duke Clinical Research Institute, Durham, NC, United States
Robert A HARRINGTON - Duke Clinical Research Institute, Durham, NC, United States
Ross M TONKENS - Regado Biosciences, Durham, NC, United States
Richard C BECKER - Duke Clinical Research Institute, Durham, NC, United States
Christopher P RUSCONI - Regado Biosciences, Durham, NC, United States
Christopher K DYKE - Alaska Heart Institute, Anchorage, United States
Shelley K MYLES - Duke Clinical Research Institute, Durham, NC, United States
Laura G ABERLE - Duke Clinical Research Institute, Durham, NC, United States
MIN MIN LIN - Duke Clinical Research Institute, Durham, NC, United States
James WALDER - Black Hills Cardiology, Rapid City, SD, United States
Steven R STEINHUBL - Cardiovascular Research Center University of Kentucky, Lexington, United States
Ian C GILCHRIST - Hershey Medical CenterPennsylvania State University, Hershey, United States
Neal S KLEIMAN - Methodist DeBakey Heart Center Baylor College of Medicine, Houston, Tex, United States
Publication Details: Circulation (New York, N.Y.), Vol.117(22), pp.2865-2874
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Cardiovascular
Language: English
Resource Type: Journal article
PMID: 18506005
Record Identifier: 991031560668402976